AstraZeneca's Board Feeling Pressure From Stockholders Following Pfizer Bid Rejection

Earlier this week, AstraZeneca's (NYSE: AZN) board rejected a bid of $119 billion from Pfizer (NYSE: PFE) to acquire the British ...